A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the overall response to desmopressin treatment among previously untreated
enuretic children aged 5-15 years after 3 and 6 months of treatment.
To investigate the influence of possible predictive factors on response after 3 and 6 months
of treatment.
To evaluate the proportion of patients achieving dryness. To evaluate the long-term safety
profile of oral desmopressin in children with primary nocturnal enuresis.